|
|
Volumn 58, Issue 5, 2002, Pages 403-410
|
|
Implications of the network structure of cellular control circuits for the design of anti-cancer vaccine therapies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
GLYCOPROTEIN GP 100;
MELANOMA ANTIGEN 3;
PROTEIN P53;
RAS PROTEIN;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER IMMUNOTHERAPY;
CANCER REGRESSION;
CELL ACTIVITY;
CELL GROWTH;
CLINICAL TRIAL;
DRUG DESIGN;
DRUG TARGETING;
GENE MUTATION;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
MATHEMATICAL ANALYSIS;
ONCOGENE;
PRIORITY JOURNAL;
STATISTICAL MODEL;
TREATMENT OUTCOME;
TUMOR SUPPRESSOR GENE;
VACCINATION;
BIOLOGICAL MODEL;
BIOMETRY;
IMMUNOLOGY;
MECHANICS;
NEOPLASM;
ANTIGENS, NEOPLASM;
BIOMETRY;
CANCER VACCINES;
DRUG DESIGN;
HUMANS;
MECHANICS;
MODELS, IMMUNOLOGICAL;
NEOPLASMS;
|
|
EID: 0036020690
PISSN: 03069877
EISSN: None
Source Type: Journal
DOI: 10.1054/mehy.2001.1523 Document Type: Article |
|
Times cited : (1)
|
|
References (31)
|
